Michael H. Rivner

机构：Augusta University · ORCID：0000-0002-6135-035X

发表论文 87 篇 · 总被引 5641 次 · h-index 31

代表论文

• Randomized Trial of Thymectomy in Myasthenia Gravis (2016 · New England Journal of Medicine · 被引 935)
• Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study (2017 · The Lancet Neurology · 被引 843)
• Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study (2023 · The Lancet Neurology · 被引 289)
• Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study (2023 · The Lancet Neurology · 被引 277)
• Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial (2019 · The Lancet Neurology · 被引 230)
• Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis (2020 · JAMA Neurology · 被引 146)